HIV INTEGRASE INHIBITORS
Compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: wherein X1, X2, Y, R1A, R1B, R2 and R3 are defined herein. The compounds are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset or progression of A...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SU DAI-SHI FISHER THORSTEN E WAI JOHN S CHOI ERIC J WILLIAMS PETER D DUBOST DAVID C EMBREY MARK W ISAACS RICHARD C A THOMPSON WAYNE J PEI TAO BALL RICHARD G VENKATRAMAN SHANKAR TRICE SARAH L |
| description | Compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: wherein X1, X2, Y, R1A, R1B, R2 and R3 are defined herein. The compounds are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset or progression of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se (or as hydrates or solvates thereof) or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. Processes for making compounds of Formula I and intermediates thereof are also described. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ZA201102620B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ZA201102620B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ZA201102620B3</originalsourceid><addsrcrecordid>eNrjZJDw8AxT8PQLcXUPcgx2BbI8PJ08Q_yDgnkYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSXyUo5GBoaGBkZmRgZMxMWoA988ftQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HIV INTEGRASE INHIBITORS</title><source>esp@cenet</source><creator>SU DAI-SHI ; FISHER THORSTEN E ; WAI JOHN S ; CHOI ERIC J ; WILLIAMS PETER D ; DUBOST DAVID C ; EMBREY MARK W ; ISAACS RICHARD C A ; THOMPSON WAYNE J ; PEI TAO ; BALL RICHARD G ; VENKATRAMAN SHANKAR ; TRICE SARAH L</creator><creatorcontrib>SU DAI-SHI ; FISHER THORSTEN E ; WAI JOHN S ; CHOI ERIC J ; WILLIAMS PETER D ; DUBOST DAVID C ; EMBREY MARK W ; ISAACS RICHARD C A ; THOMPSON WAYNE J ; PEI TAO ; BALL RICHARD G ; VENKATRAMAN SHANKAR ; TRICE SARAH L</creatorcontrib><description>Compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: wherein X1, X2, Y, R1A, R1B, R2 and R3 are defined herein. The compounds are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset or progression of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se (or as hydrates or solvates thereof) or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. Processes for making compounds of Formula I and intermediates thereof are also described.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111228&DB=EPODOC&CC=ZA&NR=201102620B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111228&DB=EPODOC&CC=ZA&NR=201102620B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SU DAI-SHI</creatorcontrib><creatorcontrib>FISHER THORSTEN E</creatorcontrib><creatorcontrib>WAI JOHN S</creatorcontrib><creatorcontrib>CHOI ERIC J</creatorcontrib><creatorcontrib>WILLIAMS PETER D</creatorcontrib><creatorcontrib>DUBOST DAVID C</creatorcontrib><creatorcontrib>EMBREY MARK W</creatorcontrib><creatorcontrib>ISAACS RICHARD C A</creatorcontrib><creatorcontrib>THOMPSON WAYNE J</creatorcontrib><creatorcontrib>PEI TAO</creatorcontrib><creatorcontrib>BALL RICHARD G</creatorcontrib><creatorcontrib>VENKATRAMAN SHANKAR</creatorcontrib><creatorcontrib>TRICE SARAH L</creatorcontrib><title>HIV INTEGRASE INHIBITORS</title><description>Compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: wherein X1, X2, Y, R1A, R1B, R2 and R3 are defined herein. The compounds are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset or progression of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se (or as hydrates or solvates thereof) or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. Processes for making compounds of Formula I and intermediates thereof are also described.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJDw8AxT8PQLcXUPcgx2BbI8PJ08Q_yDgnkYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSXyUo5GBoaGBkZmRgZMxMWoA988ftQ</recordid><startdate>20111228</startdate><enddate>20111228</enddate><creator>SU DAI-SHI</creator><creator>FISHER THORSTEN E</creator><creator>WAI JOHN S</creator><creator>CHOI ERIC J</creator><creator>WILLIAMS PETER D</creator><creator>DUBOST DAVID C</creator><creator>EMBREY MARK W</creator><creator>ISAACS RICHARD C A</creator><creator>THOMPSON WAYNE J</creator><creator>PEI TAO</creator><creator>BALL RICHARD G</creator><creator>VENKATRAMAN SHANKAR</creator><creator>TRICE SARAH L</creator><scope>EVB</scope></search><sort><creationdate>20111228</creationdate><title>HIV INTEGRASE INHIBITORS</title><author>SU DAI-SHI ; FISHER THORSTEN E ; WAI JOHN S ; CHOI ERIC J ; WILLIAMS PETER D ; DUBOST DAVID C ; EMBREY MARK W ; ISAACS RICHARD C A ; THOMPSON WAYNE J ; PEI TAO ; BALL RICHARD G ; VENKATRAMAN SHANKAR ; TRICE SARAH L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ZA201102620B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2011</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SU DAI-SHI</creatorcontrib><creatorcontrib>FISHER THORSTEN E</creatorcontrib><creatorcontrib>WAI JOHN S</creatorcontrib><creatorcontrib>CHOI ERIC J</creatorcontrib><creatorcontrib>WILLIAMS PETER D</creatorcontrib><creatorcontrib>DUBOST DAVID C</creatorcontrib><creatorcontrib>EMBREY MARK W</creatorcontrib><creatorcontrib>ISAACS RICHARD C A</creatorcontrib><creatorcontrib>THOMPSON WAYNE J</creatorcontrib><creatorcontrib>PEI TAO</creatorcontrib><creatorcontrib>BALL RICHARD G</creatorcontrib><creatorcontrib>VENKATRAMAN SHANKAR</creatorcontrib><creatorcontrib>TRICE SARAH L</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SU DAI-SHI</au><au>FISHER THORSTEN E</au><au>WAI JOHN S</au><au>CHOI ERIC J</au><au>WILLIAMS PETER D</au><au>DUBOST DAVID C</au><au>EMBREY MARK W</au><au>ISAACS RICHARD C A</au><au>THOMPSON WAYNE J</au><au>PEI TAO</au><au>BALL RICHARD G</au><au>VENKATRAMAN SHANKAR</au><au>TRICE SARAH L</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HIV INTEGRASE INHIBITORS</title><date>2011-12-28</date><risdate>2011</risdate><abstract>Compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: wherein X1, X2, Y, R1A, R1B, R2 and R3 are defined herein. The compounds are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset or progression of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se (or as hydrates or solvates thereof) or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. Processes for making compounds of Formula I and intermediates thereof are also described.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_ZA201102620B |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | HIV INTEGRASE INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T23%3A15%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SU%20DAI-SHI&rft.date=2011-12-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EZA201102620B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |